Preoperative Hormonal Evaluation for Adrenal Tumors
Mandatory Blood Tests for All Patients
- The American Urological Association recommends that all patients with adrenal tumors undergo comprehensive hormonal evaluation, including cortisol, aldosterone, and catecholamine testing, before surgical workup, regardless of tumor characteristics 1, 2
- Cortisol secretion assessment should include a 1 mg overnight dexamethasone suppression test as the preferred screening test 1
- Plasma ACTH levels should be measured as part of the cortisol secretion assessment 3
- Aldosterone secretion assessment should be performed in patients with hypertension and/or hypokalemia, and should include aldosterone-to-renin ratio and serum potassium levels 1, 4, 5
- Catecholamine excess screening should be performed using plasma metanephrines or 24-hour urinary metanephrines, and is required for all patients with adrenal masses >10 HU on non-contrast CT or with symptoms of catecholamine excess 1, 6, 7
- Androgen excess testing should be performed in specific cases, including measurement of DHEA-S, 17-OH-progesterone, androstenedione, and 17-beta-estradiol 1, 3, 8
Additional Tests to Consider
- A basic metabolic panel should be performed to assess electrolyte abnormalities that may accompany hormone-secreting tumors 5
- A complete blood count should be performed to assess for potential hematologic abnormalities that might affect surgical planning 3, 5
Important Considerations
- Hormone testing should be completed before any surgical intervention is planned, according to the American Urological Association 2, 3
- A multidisciplinary approach should be taken when reviewing results, including endocrinologists, surgeons, and radiologists, when there is evidence of hormone hypersecretion or when adrenal surgery is being considered 2, 7
- Confirmatory testing, such as saline suppression test or salt loading test, may be required based on initial results 5
Pitfalls to Avoid
- Hormone testing should not be skipped, even in apparently non-functioning tumors, as subtle hormone production can impact surgical management and perioperative care 1
- Radiological appearance cannot reliably predict hormone secretion status, and should not be relied upon solely 7
- Adrenal biopsy should not be performed without excluding pheochromocytoma, as biopsy of an undiagnosed pheochromocytoma can trigger life-threatening hypertensive crisis 6